Hospices Civils de Lyon: Hemophilia A trials
The registry lists 10 Hemophilia A studies with Hospices Civils de Lyon as lead sponsor. 3 are open to participants now and 0 have results posted.
No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®)RecruitingNCT07723560
- Monitoring of Anti-TFPI in HemophiliaRecruitingNCT07101926
- Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®)RecruitingNCT06158334
- EVALUATION of the OVERALL HAEMOSTATIC CAPACITY of MIM8 with GLOBAL HAEMOSTASIS ASSAYS and FIBRIN CLOT ULTRASTRUCTURECompletedNCT06212505
- Satisfaction Regarding the Dispensing of Emicizumab (HEMLIBRA®) for Patients With Haemophilia A in FranceCompletedNCT05450640
- Evaluation of the Training Program for Community Pharmacists for Dispensing Emicizumab (HEMLIBRA®) in FranceCompletedNCT05449197
- Bone Microarchitecture in Men With HemophiliaTerminatedNCT05127681Not applicable
- Medication Exposure in Older Patients With Constitutional Hemorrhagic DiseaseCompletedNCT04282486
- TGA (Thrombin Generation Assay) and Prophylaxis in HaemophiliaStatus unknownNCT02781766Not applicable
- Individually Tailored Prophylaxis in Patients With Severe Hemophilia ATerminatedNCT00995046Not applicable